Two new drugs, lecanemab and donanemab, have hit the market. They are designed to tackle Alzheimer's disease. They work by targeting and removing beta-amyloid protein from the brain. This protein is a key player in the development of Alzheimer's. The drugs have shown some promising results in clinical trials. They improved scores on cognitive and functional test...

Hepatocellular carcinoma (HCC) is a type of liver cancer that is notoriously tough to treat. Doctors have been experimenting with immune checkpoint inhibitors (ICIs) to fight this disease. However, these drugs can sometimes make the cancer grow faster, a condition known as hyperprogressive disease (HPD). This is bad news for patients, as it means the cancer is gettin...